What drove the big move in OBSN.SW stock today?

The sharp move was driven by heavy intraday volume of 2,351,202 shares and a steep price fall to CHF 0.0012. Catalyst risk, trading liquidity and positioning around clinical updates likely amplified the move. OBSN.SW stock reacts strongly to clinical and financing news.

What valuation metrics should investors watch for OBSN.SW stock?

Focus on cash per share (0.0915), current ratio (2.23), EPS (-0.29) and shares outstanding (117,177,000). These metrics show liquidity and dilution risk that matter more than standard PE multiples for OBSN.SW stock.

Does Meyka AI provide a price forecast for OBSN.SW stock?

Yes. Meyka AI's forecast model projects a 12-month base target of CHF 0.0050, implying +316.67% from CHF 0.0012. Forecasts are model outputs and not guarantees. Use them with clinical and financing risk analysis.

Is OBSN.SW stock suitable for long-term investors?

OBSN.SW stock is high risk for long-term portfolios due to negative earnings, pipeline dependency, and dilution risk. Long-term suitability depends on conviction in ObsEva's clinical programs and ability to finance operations.

CH Stocks

OBSN.SW ObsEva S.A. (SIX) CHF 0.0012 close 10 Mar 2026: heavy volume, catalysts

ByDanny Kontos March 11, 2026March 11, 2026

ObsEva S.A. (OBSN.SW) closed at CHF 0.0012 on 10 Mar 2026 as markets closed on SIX, posting a -76.92% intraday move and heavy volume. The dramatic drop made OBSN.SW stock one of the most active names on the Swiss exchange, trading 2,351,202 shares versus an average of 675,842. Traders and analysts are watching liquidity, clinical catalysts, and cash runway. Meyka AI monitored the session and flagged the spike for follow-up market analysis.